Maximal Tumor Eradication for Oligometastatic Prostate Cancer

NCT06972511 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Oligometastatic Prostate Cancer

Interventions

COMBINATION_PRODUCT: neoadjuvant apatamide plus ADT + radical resection of prostate cancer + extended lymph node dissection + radiotherapy of metastases
DRUG: Standard ADT treatment

Sponsor

RenJi Hospital